356 related articles for article (PubMed ID: 7767415)
1. Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome.
Garland JS; Buck RK; Allred EN; Leviton A
Arch Pediatr Adolesc Med; 1995 Jun; 149(6):617-22. PubMed ID: 7767415
[TBL] [Abstract][Full Text] [Related]
2. Hypocarbia and bronchopulmonary dysplasia.
Jobe AH
Arch Pediatr Adolesc Med; 1995 Jun; 149(6):615-6. PubMed ID: 7767414
[No Abstract] [Full Text] [Related]
3. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome.
Keszler M; Modanlou HD; Brudno DS; Clark FI; Cohen RS; Ryan RM; Kaneta MK; Davis JM
Pediatrics; 1997 Oct; 100(4):593-9. PubMed ID: 9310511
[TBL] [Abstract][Full Text] [Related]
4. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
[TBL] [Abstract][Full Text] [Related]
5. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
[TBL] [Abstract][Full Text] [Related]
6. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.
Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G
J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of three doses of a synthetic surfactant on the alveolar-arterial oxygen gradient in infants weighing > or = 1250 grams with respiratory distress syndrome. American Exosurf Neonatal Study Group II.
Berry DD; Pramanik AK; Philips JB; Buchter DS; Kanarek KS; Easa D; Kopelman AE; Edwards K; Long W
J Pediatr; 1994 Feb; 124(2):294-301. PubMed ID: 8301442
[TBL] [Abstract][Full Text] [Related]
8. Surfactant phospholipids and surface activity among preterm infants with respiratory distress syndrome who develop bronchopulmonary dysplasia.
Kazzi SN; Schürch S; McLaughlin KL; Romero R; Janisse J
Acta Paediatr; 2000 Oct; 89(10):1218-25. PubMed ID: 11083379
[TBL] [Abstract][Full Text] [Related]
9. Early respiratory management of respiratory distress syndrome in very preterm infants and bronchopulmonary dysplasia: a case-control study.
Te Pas AB; Lopriore E; Engbers MJ; Walther FJ
PLoS One; 2007 Feb; 2(2):e192. PubMed ID: 17285145
[TBL] [Abstract][Full Text] [Related]
10. Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia.
Yeh TF; Chen CM; Wu SY; Husan Z; Li TC; Hsieh WS; Tsai CH; Lin HC
Am J Respir Crit Care Med; 2016 Jan; 193(1):86-95. PubMed ID: 26351971
[TBL] [Abstract][Full Text] [Related]
11. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
12. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
[TBL] [Abstract][Full Text] [Related]
13. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
[TBL] [Abstract][Full Text] [Related]
14. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
15. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P
J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
[TBL] [Abstract][Full Text] [Related]
16. A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants.
Lang MJ; Hall RT; Reddy NS; Kurth CG; Merritt TA
J Pediatr; 1990 Feb; 116(2):295-300. PubMed ID: 2405141
[TBL] [Abstract][Full Text] [Related]
17. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomized multicenter comparison of high-frequency oscillatory ventilation and conventional ventilation in preterm infants of less than 30 weeks with respiratory distress syndrome.
Moriette G; Paris-Llado J; Walti H; Escande B; Magny JF; Cambonie G; Thiriez G; Cantagrel S; Lacaze-Masmonteil T; Storme L; Blanc T; Liet JM; André C; Salanave B; Bréart G
Pediatrics; 2001 Feb; 107(2):363-72. PubMed ID: 11158471
[TBL] [Abstract][Full Text] [Related]
19. Nasal CPAP or intubation at birth for very preterm infants.
Morley CJ; Davis PG; Doyle LW; Brion LP; Hascoet JM; Carlin JB;
N Engl J Med; 2008 Feb; 358(7):700-8. PubMed ID: 18272893
[TBL] [Abstract][Full Text] [Related]
20. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
